Nabumetone Tablet
Product Images NDC 68788-7765

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 68788-7765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nabumetone Tablet Usp 500mg (Container1)

This is a description of Nabumetone Tab USP 500mg produced by ScieGen Pharmaceuticals. Each tablet contains Nabumetone USP 500mg, and it is the generic for Relafen. It is cautioned that federal law prohibits transfer of this drug to anyone other than the patient it was prescribed to. The package dimensions, batch number, production number, and expiration date are also given, along with storage instructions.*

FDA Label Image

Figure1 (Figure1)

This is a study report showing the plasma concentration of the active metabolite (BMNA) of Nabumetone medication in patients who were given 1000mg and 2000mg doses once daily. The data includes the number of patients (31 and 12) and the time period (in hours) for which the concentration of BMNA was measured.*

FDA Label Image

Structure1 (Structure1)

FDA Label Image

Structure2 (Structure2)

6-methoxy-2-naphthylacetic acid (SMNA) is a chemical compound with the molecular formula COOH-CHgO. It is an organic acid that contains a naphthalene ring and a carboxylic acid functional group. SMNA is often used in research and pharmaceuticals.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.